![]() |
|
Home → Volume 1/ Issue 3 → Medical Treatment → Methotrexate
F. Medical Treatment
Methotrexate
45. The role of subutaneous methotrexate in children with
JIA who have failed oral methotrexate
Khariah A Alsufyani, Oliva Ortiz-Alvarez, Peter N Malleson,
David A Cabral, Lori B Tucker, Ross E Petty
46. Long term monitoring of methotrexate toxicity in
children with juvenile idiopathic arthritis suggests that guidelines for
frequency of blood test monitoring should be modified
O Ortiz-Alvarez, G Avery, J Green, RE Petty, LB Tucker, PN Malleson, DA Cabral.
47. Methotrexate-induced nodulosis in juvenile idiopathic
arthritis: An uncommon event with spontaneous resolution
R
Adwani, R Scuccimarri, CM Duffy
48. Methotrexate in JCA: Defining its efficacy.
A systematic review
VW Cartwright, FM Wolf
49. Etanercept/methotrexate registry in juvenile rheumatoid
arthritis
EH Giannini, DJ Lovell, TM Sherrard, NT Ilowite, AA Reiff, the PRCSG